U.S. Oral Surgery Management Enters Maryland, Adds Five New Partner Practices in Five States
March 19, 2024 08:45 ET
|
U.S. Oral Surgery Management (USOSM)
U.S. Oral Surgery Management is announcing partnerships with five new practices, including its first in the state of Maryland.
Pharmaceutical Packaging Market Estimated to Reach $269.9 billion by 2028 Globally, at a CAGR of 15.4%, says MarketsandMarkets™
March 19, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, March 19, 2024 (GLOBE NEWSWIRE) -- The Global Pharmaceutical Packaging Market size is projected to reach USD 269.9 billion by 2028 from USD 132.0 billion in 2023, at a CAGR of 15.4% during...
Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates
March 19, 2024 08:30 ET
|
Enliven Therapeutics, Inc.
Financing includes participation from new and existing investors Net proceeds, along with existing cash, cash equivalents and marketable securities, are expected to extend cash runway into late 2026...
Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient
March 19, 2024 08:30 ET
|
Atossa Therapeutics, Inc.
SEATTLE, March 19, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that the pre-menopausal, Estrogen Receptor positive (ER+) / Human...
Gene Expression Analysis Market Size Projected to Reach USD 7.32 Billion by 2032, Expecting 7.8% CAGR Growth: Report by Polaris Market Research
March 19, 2024 08:11 ET
|
Polaris Market Research & Consulting LLP
New York, NY, March 19, 2024 (GLOBE NEWSWIRE) -- Global gene expression analysis market size and share was valued at USD 3.73 billion in 2023 and is anticipated to generate an estimated revenue of...
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
March 19, 2024 08:07 ET
|
ClearPoint Neuro, Inc.
ClearPoint Neuro's partner's completed BLA Submission for Upstaza™ would be first disease-modifying treatment for AADC Deficiency in the US.
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
March 19, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024
March 19, 2024 08:00 ET
|
Ludwig Enterprises, Inc.
SPARKS, Nev., March 19, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc, (OTC: LUDG): A US-based biotechnology company is pleased to announce it has entered the booming artificial intelligence...
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance
March 19, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer...
Rejuvenation Medical Group of Canada uses MedMatrix AI Reporter to Streamline Reporting and Improve Operations
March 19, 2024 08:00 ET
|
MedBright AI Investments Inc.
Rejuvenation Medical Group of Canada uses MedMatrix AI Reporter to Streamline Reporting and Improve Operations